Neurogene
NGNE
NGNE
82 hedge funds and large institutions have $249M invested in Neurogene in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
27% less capital invested
Capital invested by funds: $342M → $249M (-$93.1M)
64% less call options, than puts
Call options by funds: $703K | Put options by funds: $1.97M
Holders
82
Holding in Top 10
–
Calls
$703K
Puts
$1.97M
Top Buyers
| 1 | +$4.73M | |
| 2 | +$2.63M | |
| 3 | +$1.41M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$694K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$419K |
Top Sellers
| 1 | -$7.05M | |
| 2 | -$3.93M | |
| 3 | -$3.17M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$1.83M |
| 5 |
Goldman Sachs
New York
|
-$1.2M |